1. Home
  2. CELU vs MOBX Comparison

CELU vs MOBX Comparison

Compare CELU & MOBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELU
  • MOBX
  • Stock Information
  • Founded
  • CELU 2016
  • MOBX 2020
  • Country
  • CELU United States
  • MOBX United States
  • Employees
  • CELU N/A
  • MOBX N/A
  • Industry
  • CELU Biotechnology: Pharmaceutical Preparations
  • MOBX
  • Sector
  • CELU Health Care
  • MOBX
  • Exchange
  • CELU Nasdaq
  • MOBX Nasdaq
  • Market Cap
  • CELU 64.3M
  • MOBX 57.1M
  • IPO Year
  • CELU N/A
  • MOBX N/A
  • Fundamental
  • Price
  • CELU $2.20
  • MOBX $0.83
  • Analyst Decision
  • CELU Strong Buy
  • MOBX
  • Analyst Count
  • CELU 1
  • MOBX 0
  • Target Price
  • CELU $6.00
  • MOBX N/A
  • AVG Volume (30 Days)
  • CELU 211.1K
  • MOBX 1.5M
  • Earning Date
  • CELU 08-29-2025
  • MOBX 08-13-2025
  • Dividend Yield
  • CELU N/A
  • MOBX N/A
  • EPS Growth
  • CELU N/A
  • MOBX N/A
  • EPS
  • CELU N/A
  • MOBX N/A
  • Revenue
  • CELU $44,590,000.00
  • MOBX $10,984,000.00
  • Revenue This Year
  • CELU N/A
  • MOBX N/A
  • Revenue Next Year
  • CELU $76.00
  • MOBX N/A
  • P/E Ratio
  • CELU N/A
  • MOBX N/A
  • Revenue Growth
  • CELU 4.45
  • MOBX 180.13
  • 52 Week Low
  • CELU $1.00
  • MOBX $0.55
  • 52 Week High
  • CELU $5.22
  • MOBX $2.47
  • Technical
  • Relative Strength Index (RSI)
  • CELU 38.52
  • MOBX 41.04
  • Support Level
  • CELU $1.97
  • MOBX $0.80
  • Resistance Level
  • CELU $2.25
  • MOBX $0.99
  • Average True Range (ATR)
  • CELU 0.22
  • MOBX 0.09
  • MACD
  • CELU -0.00
  • MOBX -0.02
  • Stochastic Oscillator
  • CELU 32.50
  • MOBX 19.08

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

About MOBX Mobix Labs Inc.

Mobix Labs Inc. specializes in designing, developing, and selling components and systems for wireless and wired connectivity, radio frequency (RF) technologies, switching, and electromagnetic interference (EMI) filtering solutions. The company serves markets, including commercial, industrial, automotive, medical, aerospace, defense, and others.

Share on Social Networks: